Clinical Trials Sponsored by Farmos Oy

Total 1432 results

Universidad Rey Juan Carlos

Unknown

Virtual Reality and Manual Dexterity in in Patients With Multiple Sclerosis

Multiple Sclerosis | Physical Activity | Upper Limb | Virtual Reality | Dexterity

Spain
Universidad Rey Juan Carlos

Completed

Effects of Pain, Disability and Cervicokinesthesia After Cervical Manipulation

Neck Pain

Spain
Hospital San Carlos, Madrid

Unknown

ΔvapCO2 / Cav02 Ratio as a Prognostic Marker and Predictor of Complications After Cardiac Surgery

Postoperative Complications | Shock | Cardiac Surgery | Disorder of Blood Gas

Spain
Universidad Rey Juan Carlos

Completed

Ischemic Compression on Post-needling Soreness

Neck Pain

Spain
Universidad Rey Juan Carlos

Completed

Effect of Kinesio® Taping in Chronic Ankle Instability

Ankle Sprain

Spain
Universidad Rey Juan Carlos

Completed

Thoracic Manipulation and Mobilization for Neck Pain

Neck Pain

Spain
Hospital San Carlos, Madrid

Unknown

Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient (SADI vs CD)

Morbid Obesity

Spain
Hospital Carlos III, Madrid

Unknown

Simplification From Protease Inhibitors to Raltegravir (ODIS)

HIV Infections

Spain
Hospital Carlos III, Madrid

Completed

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies (PILOT-NR)

HIV Infections | Chronic Hepatitis C

Spain
Hospital Carlos III, Madrid

Unknown

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients (PERICO)

Chronic Hepatitis C

Spain
Hospital San Carlos, Madrid
Instituto de Salud Carlos III; FUNDACION PARA LA INVESTIGACION HOSPITAL CLINICO...

Recruiting

Biological Factors Associated With Subclinical Valvular Thrombosis (START)

Aortic Stenosis

Spain
Jonsson Comprehensive Cancer Center
Kate Farms Inc

Recruiting

Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy

Locally Advanced Head and Neck Carcinoma

United States
PT Bio Farma

Completed

Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates

Rotavirus Gastroenteritis

Indonesia
PT Bio Farma

Completed

Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)

Human Papilloma Virus Infection

Indonesia
Faron Pharmaceuticals Ltd

Terminated

Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19 (HIBISCUS)

Covid19

United States
PT Bio Farma

Completed

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Safety Issues | Immunogenicity

Indonesia
Faron Pharmaceuticals Ltd

Terminated

Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA (INFORAAA)

Preventive Medicine | Multi Organ Failure

Lithuania, Estonia, Finland
PT Bio Farma

Completed

Safety Profile Following Pentabio Vaccination in Indonesian Infants

Healthy

Indonesia
PT Bio Farma

Completed

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

Healthy

Indonesia
PT Bio Farma

Completed

Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial

Healthy

Indonesia
PT Bio Farma

Completed

The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)

Healthy

Indonesia
Faes Farma, S.A.

Completed

Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Chronic Urticaria | Allergic Rhinoconjunctivitis

Australia, Germany, Sweden
Faes Farma, S.A.

Completed

Oral Bioavailability of Bilastine (BIOBI)

Healthy

Spain
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension

Perennial Allergic Rhinitis
Faes Farma, S.A.

Completed

A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

Seasonal Allergic Rhinitis
Faes Farma, S.A.

Completed

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber

Seasonal Allergic Rhinitis

Austria
Kanta-Häme Central Hospital
Linnan Klinikka Oy; Finnish Red Cross Blood Service; MTT Agrifood Research Finland

Completed

Hämeenlinna Metabolic Syndrome Research Program: Effects of Rapeseed Oil on Serum Lipids and Platelet Function (HMS-03)

Metabolic Syndrome

Finland
PT Bio Farma

Recruiting

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial

Safety Issues | Effect of Drug

Indonesia
PT Bio Farma

Not yet recruiting

Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

COVID-19
Ramos Mejía Hospital

Recruiting

Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19

Acute Respiratory Distress Syndrome | Recruitment | COVID-19 Pneumonia

Argentina
Faron Pharmaceuticals Ltd

Completed

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)

Cancer

Finland, United Kingdom, Netherlands, United States, France, Spain
Faes Farma, S.A.

Completed

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency (WORFEROL)

Vitamin D Deficiency | Vitamin D Insufficiency

Spain, France, Bulgaria, Czechia, Italy, Serbia, Slovakia
Ramos Mejía Hospital

Completed

Mechanical Power and Ventilatory Ratio in ARDS

Acute Respiratory Distress Syndrome

Argentina
PT Bio Farma

Completed

Protectivity and Safety Following Recombinant Hepatitis B Vaccine

Immunogenicity

Indonesia
Faron Pharmaceuticals Ltd

Withdrawn

A Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon Carcinoma (RENACOL)

Carcinoma, Renal Cell | Carcinoma Colon

Finland
PT Bio Farma

Completed

Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B

Safety | Immunogenicity

Indonesia
InnoUp Farma S.L.

Unknown

Oral Immunotherapy for Peanut Allergic Patients

Peanut Allergy

Spain
PT Bio Farma

Completed

Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

Safety Issues | Immunogenicity

Indonesia
PT Bio Farma

Completed

Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine

Healthy

Indonesia
PT Bio Farma

Completed

Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)

Healthy

Indonesia
PT Bio Farma

Completed

Safety of Hib Vaccine (Bio Farma)

Healthy

Indonesia
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Ramos Mejía Hospital

Recruiting

Ventilatory Parameters in Acute Neurological Injury

Stroke | Traumatic Brain Injury | Subarachnoid Hemorrhage | Neurologic Decompensation, Acute

Argentina
Faes Farma, S.A.

Not yet recruiting

Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

Colitis, Ulcerative
Archivel Farma S.L.

Recruiting

Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis (CONSTAN-ARG)

Tuberculosis, Pulmonary

Argentina
Faron Pharmaceuticals Ltd

Recruiting

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (BEXMAB)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Relapsed/Refractory AML

United States, Finland
Archivel Farma S.L.

Active, not recruiting

Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)

Tuberculosis, Pulmonary

India
PT Bio Farma

Completed

Post Marketing Surveillance of Diphtheria Antitoxin (DAT)

Safety Issues

Indonesia
PT Bio Farma

Completed

Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children

Hepatitis B

Indonesia
PT Bio Farma

Completed

Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia

Safety Issues

Indonesia

3

Subscribe